Frailty signals in older users of GLP-1 obesity drugs, while rare, warrant attention Frailty conditions in older GLP-1 users are linked with relatively high risks of adverse outcomes Study underscores ...
Samsung and Mass General are studying whether Galaxy Watch8 data can help doctors monitor muscle loss during GLP-1 weight-loss treatment more closely. Ozempic-style drugs have changed how people lose ...
Man of Many on MSN
WHOOP data reveals what GLP-1 drugs do to your heart
GLP-1 drugs like Ozempic and Wegovy have rewritten the weight-loss conversation almost overnight, but nearly everything we hear about them comes down to the number on the scale. What actually ...
July 14 (Reuters) - Potential signs of frailty in older adults taking Eli Lilly’s GLP-1 obesity drug Zepbound may signal relatively high risks for adverse outcomes, according to a large study that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results